Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953233 · ClinicalTrials.gov registry record · NA
School Inner City Air Study
A NA study of Viral Infection, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05953233 is a NA study of Viral Infection that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05953233, a NA study of Viral Infection, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to answer are: * Do classroom HEPA cleaners reduce exposure to viruses? * Do classroom HEPA cleaners reduce student and teacher infections? * Do classroom HEPA cleaners reduce infections in family members?
Conditions Studied
Interventions
- OTHER Active classroom HEPA cleaner
- OTHER Sham classroom HEPA cleaner
Study Locations (1)
Massachusetts
- Mass General Brigham - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2030-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05953233
The ClinicalTrials.gov registry entry for NCT05953233 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 211-participant average among 11 other Viral Infection trials with a reported enrollment target. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Viral Infection appearing as the primary indexed condition, and to 2 interventions - of which Active classroom HEPA cleaner is the first listed.
NCT05953233 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05953233 about?
NCT05953233 is a clinical study titled "School Inner City Air Study". The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to a...
What is the current status of trial NCT05953233?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-09-15. Estimated completion is 2030-08.
What conditions does trial NCT05953233 study?
This clinical trial studies the following conditions: Viral Infection.
What interventions are being tested in trial NCT05953233?
The interventions under investigation include: Active classroom HEPA cleaner (OTHER), Sham classroom HEPA cleaner (OTHER).
Who is sponsoring clinical trial NCT05953233?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05953233 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Viral Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
RECRUITING · NA
-
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
ACTIVE NOT RECRUITING · NA
-
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RECRUITING · Phase 1
-
Third Party Viral Specific T-cells (VSTs)
RECRUITING · Phase 2
-
Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis
RECRUITING · Phase 1
-
Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.